Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Donor graft does not affect the P450 2C19 genotype expressed in peripheral blood in recipients of living donor liver transplantation.

Clinical transplantation - 1 Jan 2000

Chiu King-Wah, Tai Wei-Chen, Nakano Toshiaki, Tseng Hui-Peng, Cheng Yu-Fan, Jawan Bruno, Goto Shigeru, Chen Chao-Long

Abstract excerpt

The function of cytochrome P450 2C19 (CYP2C19) is altered in patients with end-stage liver disease (ESLD) that require liver transplantation (LT). The status of CYP2C19 is of considerable interest because the transplanted healthy donor livers are perfused with the blood of the recipient with ESLD. This study aims to clarify the changes in CYP2C19 in the peripheral blood before and after LT. Thirty pairs of living...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aryl Hydrocarbon Hydroxylases
Share to Cytochrome P-450 CYP2C19

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to End Stage Liver Disease

Share to Graft Rejection

Share to Leukocytes, Mononuclear

Share to Liver Failure

Share to Liver Transplantation

Share to Living Donors

Source

Identifiers

PMID: 20236133
DOI: 10.1111/j.1399-0012.2010.01220.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Donor graft does not affect the P450 2C19 genotype expressed in peripheral blood in recipients of living donor liver transplantation.PMID 20236133Read ↗

Homogenous phenomenon of graft liver CYP2C19 genotypes after living donor liver transplantation.Semantic proximity Read ↗

Western blotting analysis for quantitative detection of CYP2C19 expression in liver tissues in the setting of living donor liver transplantation.Semantic proximity Read ↗

Identification of IL-28B Genotype Modification in Hepatocytes after Living Donor Liver Transplantation by Laser Capture Microdissection and Pyrosequencing Analysis.Semantic proximity Read ↗

Cytochrome P450 2C19 loss-of-function polymorphism is associated with an increased treatment-related mortality in patients undergoing allogeneic transplantation.Semantic proximity Read ↗

Pyrosequencing to identify homogeneous phenomenon when using recipients/donors with different CYP3A5*3 genotypes in living donor liver transplantation.Semantic proximity Read ↗

The recipient CYP2D6 allele 4-associated poor metabolizer status correlates with an early fibrosis development after liver transplantation.Semantic proximity Read ↗

Immunological aspects in late phase of living donor liver transplant patients: usefulness of monitoring peripheral blood CD4+ adenosine triphosphate activity.Semantic proximity Read ↗

Impact of glutathione S-transferase T1 gene polymorphisms on acute cellular rejection in living donor liver transplantation.Semantic proximity Read ↗

Drug-induced liver graft toxicity caused by cytochrome P450 poor metabolism.Semantic proximity Read ↗

Glutathione S-transferase T1 genetic mismatch is a risk factor for de novo immune hepatitis in liver transplantation.Semantic proximity Read ↗

Determination of IL28B polymorphisms in liver biopsies obtained after liver transplantation.Semantic proximity Read ↗

Reassessing the impact of donor HLA-C genotype on long-term liver transplant survival.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.